Results 311 to 320 of about 95,633 (353)
Some of the next articles are maybe not open access.

Neuromuscular Blocking Agents

1990
In animal experiments succinylcholine increases ICP (Cottrell et al. 1983, Lanier et al. 1986). The increase in ICP is also observed after pre-treatment with thiopentone (Thiagarajah et al. 1988). In dogs subjected to succinylcholine injection, CBF increases within a few minutes and this hyperperfusion is accompanied by EEG activation (Mori et al. 1973,
Jörn Bo Madsen, Georg Emil Cold
openaire   +1 more source

Disadvantages of Neuromuscular Blocking Agents

Veterinary Clinics of North America: Small Animal Practice, 1992
Neuromuscular blocking agents have few indications and significant contraindications or problems associated with their use. The need for controlled ventilation and the difficulties of monitoring anesthetic depth when using neuromuscular blocking agents are overriding factors that mitigate against their routine use.
openaire   +2 more sources

Neuromuscular Blocking Agents in ARDS

New England Journal of Medicine, 2010
In this issue of the Journal, Papazian and colleagues1 present intriguing results of their study examining neuromuscular blockade in patients with severe, early acute respiratory distress syndrome (ARDS). The investigators randomly assigned 340 patients to receive the neuromuscular blocking agent cisatracurium or placebo for a period of 48 hours.
openaire   +2 more sources

Neuromuscular blocking agents

2023
Manuel Martin Flores, Bhupinder Singh
openaire   +1 more source

Neuromuscular Blocking Agents

Neuromuscular Blocking Agents (NMBAs) are essential in anesthesia for muscle relaxation during surgical procedures. They are classified into non-depolarizing and depolarizing agents, with depolarizing agents activating acetylcholine receptors and non-depolarizing agents blocking them.
openaire   +1 more source

Neuromuscular blocking agents

The American Journal of Medicine, 1955
openaire   +2 more sources

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Neuromuscular Blocking Agents

Veterinary Clinics of North America: Small Animal Practice, 1992
openaire   +2 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel   +2 more
exaly  

Home - About - Disclaimer - Privacy